EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of Chikungunya Virus Infection during an Outbreak in Myanmar

Mya Myat Ngwe Tun, Aung Kyaw Kyaw iD, Khine Mya Nwe, Su Su Myaing, Ye Thu Win, Shingo Inoue, Yuki Takamatsu, Takeshi Urano, Hlaing Myat Thu, Saw Wutt Hmone, Kyaw Zin Thant, Kouichi Morita

Viruses · 2023

DOI: 10.3390/v15081734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Mya Myat Ngwe Tun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: Chikungunya Fever, Chikungunya virus, Dengue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMED (Japan Agency of Medical Research and Development) under SCARDA, e-Asia, Joint Research of Department of Medical Research, Ministry of Health, Myanmar and Institute of Tropical Medicine, Nagasaki University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) infection is a re-emerging arboviral disease with no approved vaccine, although numerous options are in development. Before vaccine implementation, disease burden, affected age group, and hospitalization rate information should be documented. In 2019, a sizeable outbreak of the East Central South African genotype of CHIKV occurred in Myanmar, and during this period, a cross-sectional study was conducted in two regions, Mandalay and Yangon, to examine the molecular and seropositivity rate of the CHIKV infection. The participants (1124) included dengue-suspected pediatric patients, blood donors, and healthy volunteers, who were assessed using molecular assays (quantitative real-time RT-PCR), serological tests (anti-CHIKV IgM capture and IgG indirect enzyme-linked immunosorbent assays), and neutralization tests. The tests confirmed the following positivity rates: 11.3% (127/1124) for the molecular assay, 12.4% (139/1124) for the anti-CHIKV IgM Ab, 44.5% (500/1124) for the anti-CHIKV IgG Ab, and 46.3% (520/1124) for the CHIKV neutralizing Ab. The highest rate for the molecular test occurred with the dengue-suspected pediatric patients. The seroprevalence rate through natural infection was higher in the healthy volunteers and blood donors than that in the pediatric patients. The results of this study will help stakeholders determine the criteria for choosing appropriate recipients when a CHIKV vaccine is introduced in Myanmar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverChikungunya virusDengueHumansChildMyanmarCross-Sectional StudiesSeroepidemiologic StudiesAntibodies, ViralDisease OutbreaksImmunoglobulin MImmunoglobulin G

Stichwörter der Autor:innen

Myanmarchikungunya burdenmolecular detectionseropositivity

Substanzen

Antibodies, ViralImmunoglobulin MImmunoglobulin G

Autor:innen und Institutionen

  • Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan.
  • Department of Medical Research, Ministry of Health, Yangon 11191, Myanmar.
  • 550-Bedded Children Hospital (Mandalay), Department of Medical Services, Ministry of Health, Mandalay City 05021, Myanmar.
  • Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

ORCID-Profile: Aung Kyaw Kyaw

Förderung

  • AMED (Japan Agency of Medical Research and Development) under SCARDA
  • e-Asia
  • Joint Research of Department of Medical Research, Ministry of Health, Myanmar and Institute of Tropical Medicine, Nagasaki University
  • JSPS (Japan Society for the Promotion of Science)
  • Naito Foundation, Takeda Science Foundation, and National Science Foundation

Zitieren

APA

Ngwe Tun, M. M., Kyaw, A. K., Nwe, K. M., Myaing, S. S., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Hmone, S. W., Thant, K. Z., & Morita, K. (2023). Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses. https://doi.org/10.3390/v15081734

Vancouver

Ngwe Tun MM, Kyaw AK, Nwe KM, Myaing SS, Win YT, Inoue S, et al. Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses. 2023. doi:10.3390/v15081734

BibTeX
@article{NgweTun2023,
  author = {Ngwe Tun, Mya Myat and Kyaw, Aung Kyaw and Nwe, Khine Mya and Myaing, Su Su and Win, Ye Thu and Inoue, Shingo and Takamatsu, Yuki and Urano, Takeshi and Thu, Hlaing Myat and Hmone, Saw Wutt and Thant, Kyaw Zin and Morita, Kouichi},
  title = {Burden of Chikungunya Virus Infection during an Outbreak in Myanmar},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15081734}
}
Kostenlos starten →